Xencor | XNCR - Umlaufvermögen

Aktienkurs
12.98
Täglich Wechseln
0.53 4.26%
Monatlich
4.68%
Jährlich
23.50%
Q2 Prognose
12.70




Umlaufvermögen Veränderung Datum
AbbVie USD 29.06B 523M 2025-12
Alnylam Pharmaceuticals USD 4.05B 97.85M 2025-12
Amgen USD 29.06B 1.17B 2025-12
Arrowhead Research USD 1.17B 223.75M 2025-12
AstraZeneca USD 28.72B 1.22B 2025-12
Biogen USD 8.97B 37.5M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Cytokinetics USD 916.97M 60.37M 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
J&J USD 59.17B 3.55B 2026-03
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12
MacroGenics USD 219.94M 12.15M 2025-12
Merck USD 47.56B 10.49B 2025-09
Novartis USD 30.46B 2.26B 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
Xencor USD 599.82M 81.38M 2025-12